KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Intangibles: 2018-2022

Historic Intangibles for Castle Biosciences (CSTL) over the last 1 years, with Mar 2022 value amounting to $87.3 million.

  • Castle Biosciences' Intangibles was N/A to $87.3 million in Q1 2022 from the same period last year, while for Mar 2022 it was $87.3 million, marking a year-over-year change of. This contributed to the annual value of $88.9 million for FY2021, which is N/A change from last year.
  • Per Castle Biosciences' latest filing, its Intangibles stood at $87.3 million for Q1 2022, which was down 1.85% from $88.9 million recorded in Q4 2021.
  • In the past 5 years, Castle Biosciences' Intangibles ranged from a high of $88.9 million in Q4 2021 and a low of $4,000 during Q4 2018.
  • Moreover, its 2-year median value for Intangibles was $60.0 million (2021), whereas its average is $60.3 million.